Moderna lands $450m in funding for drug research

Moderna Therapeutics Inc. , a three-year-old Cambridge company working on 45 experimental drugs in the emerging field of messenger RNA technology, said Monday that it has landed $450 million in new financing -- one of the largest private biotech investments ever. The capital infusion will enable Moderna to add 100 employees to its 145-person workforce over the coming year, expand into larger quarters around Kendall Square, and push the first batch of its drug candidates into clinical trials during the next two years, the company said.

http://ift.tt/1Ai2QV8